Clinical trial
Effect of Insulin Sensitizer Therapy on Atherothrombotic and Inflammatory…
NCT00443755 · Mayo Clinic, Other · Completed
Key facts
| NCT number | NCT00443755 |
|---|---|
| Title | Effect of Insulin Sensitizer Therapy on Atherothrombotic and Inflammatory Profiles Associated With Insulin Resistance |
| Official title | Effect of Insulin Sensitizer Therapy on Atherothrombotic and Inflammatory Profiles Associated With Insulin Resistance |
| Lead sponsor | Mayo Clinic, Other |
| Collaborators | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) NIH Takeda Pharmaceuticals North America, Inc. Industry National Center for Research Resources (NCRR) |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Type 2 Diabetes, Insulin Resistance, Metabolic Syndrome |
| Intervention type | Drug |
| Interventions | metformin, pioglitazone, Placebo |
| Enrollment | 28 |
| Start date | Aug 1, 2005 |
| Primary completion | Aug 1, 2010 |
| Completion | Aug 1, 2010 |
| First posted | Mar 6, 2007 |
| Last update posted | Oct 31, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: